Notice Title

Consent to the Distribution of New Medicines

Publication Date
21 Nov 2024

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2024-go5896
Title
View PDF
File Type and Size
PDF (35 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Beriplex NZ
Active Ingredients: Factor II 400IU
Factor IX 400IU
Factor VII 200IU
Factor X 440IU
Protein C 300IU
Protein S precursor 240IU
Prothrombin complex concentrates 120mg
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: CSL Behring (NZ) Limited
Manufacturer: CSL Behring GmbH, Marburg, Germany
   
Product: Testosterone undecanoate
Active Ingredient: Testosterone undecylate 250mg/mL equivalent to testosterone 157.9mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Laboratorios Farmalan S.A., Leon, Spain


Dated this 15th day of November 2024.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).